QualityStocksNewsBreaks Archives - Page 794 of 1423

MondayJan 11, 2021 12:57 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O’Toole and Sylvia Moir

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced the appointment of Kathleen O’Toole, retired commissioner of Boston and Seattle Police Departments, and Sylvia Moir, retired chief of Tempe Police Department, to join the company’s public safety technology development and agency relations efforts. “As WRAP continues to drive innovations in public safety, we are proud to welcome two highly accomplished leaders,” said Tom Smith, president and interim CEO at WRAP. “Ret. Chief O’Toole and Ret. Chief Moir each hold decades of career experience in law enforcement as well as historic positions as inaugural female chiefs of their…

MondayJan 11, 2021 12:30 pm

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at CES 2021 Virtual Conference

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will exhibit virtually at the CES 2021 all digital event, Jan. 12-14, 2021. According to the update, the company will present the latest developments to its proprietary automatic calibration software solution, designed to ensure that stereo cameras remain calibrated regardless of their configuration or position, to create accurate and continuous depth perception. In addition, Foresight will discuss how its unique solution enables separation of stereo cameras in order to allow flexible placement of cameras on the vehicle, increase the baseline between the cameras,…

MondayJan 11, 2021 12:10 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the Biotech Showcase(TM) Digital 2021 Conference. According to the update, the conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Dr. James Woody, Chief Executive Officer, will provide an overview of 180 Life Sciences and the company’s progress in key programs. In addition, 180 Life Sciences will host one-on-one meetings with investors and…

MondayJan 11, 2021 11:47 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company's appointment of Stephen R. Brooks as its new chief financial officer and Peter Rizakos as the firm's new general counsel. According to the update, these appointments complete the company's new top management team put into place by Dr. McIntyre and the Champignon Board of Directors. "These new management additions ready us for the future where the Company's clinical products and services will help meet the enormous public need that is creating significant public demand for improved, ketamine-based treatments that are capable of rapid response…

MondayJan 11, 2021 11:19 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Strategic Partnership with Kernel

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is excited to announce that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel (“Kernel”) to leverage its innovative technology, Kernel Flow (“Flow”), for its upcoming sponsored clinical work. “Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction. Currently, clinical investigators rely on limited subjective information from patients. The ability to collect quantitative data from our sponsored drug development programs is potentially…

FridayJan 08, 2021 12:36 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Shifts to Drive Opportunity in the EV Fast Lane

Net Element (NASDAQ: NETE) is a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. On the heels of success in the global financial technology sector, providing next-generation electronic payments solutions spanning across point-of-sale, e-commerce and mobile devices, Net Element is preparing for life in the fast lane as it shifts into the EV space. Under the leadership of CEO Oleg Firer, a veteran entrepreneur and corporate turn-around specialist, Net Element realized exponential revenue growth from $0 in 2013 to $65…

FridayJan 08, 2021 12:21 pm

QualityStocksNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) COO Shines the Spotlight on Proprietary Tech, Unique Value Proposition

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, was featured in a recent SmallCap-Investor interview. The company’s COO Colin Bletsky joined the interview to discuss MustGrow and its unique value proposition and ambitious plans for the future. Bletsky explained that a rigorous scientific process stands behind MustGrow’s proprietary technology, in which the company has invested more than $10 million. MustGrow has also conducted an estimated 110 studies in the field and worked with third-party companies, leading to the ownership of approximately 100 patents The company is…

FridayJan 08, 2021 12:19 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $3M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 3,650,840 shares of its common stock at a purchase price of $0.842 per share. The company expects to secure gross proceeds of approximately $3.0 million in the registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase an aggregate of up to 1,825,420 shares of…

FridayJan 08, 2021 11:56 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Issues Letter to Shareholders

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today issued a letter to its shareholders and the investment community from its CEO and President James Sapirstein. The letter discusses AzurRx BioPharma’s optimism and enthusiasm for 2021 and its extraordinary accomplishments in the face of so many recent challenges. “This year, already, we are building on the momentum and wasted no time in making an impact with the announcement of a transformative in-licensing agreement with First Wave Bio, bringing in a new asset and two new GI indications into our development fold,”…

FridayJan 08, 2021 11:31 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Article Outlining Future Potential in Novel Agents for Bipolar Disorders

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc. The article, “Bipolar Disorders” is published in The Lancet – one of the world's best-known and most reputable scientific journals in medicine. According to the update, the article contributes to The Lancet 's collection of peer-reviewed seminars and provides a "state-of-the-art overview of bipolar disorders, covering epidemiology, parthenogenesis, diagnosis, treatment, and prevention, while highlighting relevant clinical controversies." "The availability of so-called rapid-onset treatments (e.g., ketamine) and treatments that could mitigate suicidality is crucial to clinical settings,"…

Site Search

Company Search

Category: QualityStocksNewsBreaks